Atai Archives - Beragam Pengetahuan

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) – Beragampengetahuan

3 mins read

Trading

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) – Beragampengetahuan

Januari 7, 2024 Maximal0Tagged 100M, approval, Atai, beragampengetahuan, Compass, developer, Funding, Life, MDMA, NASDAQATAI, NASDAQCMPS, pathways, Psychedelics, PTSD, Sciences, Secures, Series, support, Treat

A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation has secured over $100 million in a Series A private stock sale. The funds will support the final stages of its application for regulatory approval to sell MDMA, also known as ecstasy, as a treatment […]

Atai Mempresentasikan R-Ketamine Melalui Studi Menjembatani Fase I, Pembaruan, dan Pandangan Jangka Dekat – ATAI Life Sciences (NASDAQ: ATAI) – Beragampengetahuan

April 15, 2023 Maximal0Tagged Atai, beragampengetahuan, dan, dekat, Fase, jangka, Life, melalui, Mempresentasikan, Menjembatani, NASDAQ, Pandangan, Pembaruan, RKetamine, Sciences, Studi

Perusahaan biofarmasi tahap klinis Atay Life Sciences ATAI Mengumumkan dosis zat dalam Tahap I substudi milik mayoritas Perception Neuroscience melalui pemberian intravena ke subkutan R-ketamin, PCN-101. Label terbuka, uji coba disiapkan untuk mengevaluasi keamanan, tolerabilitas, dan farmakokinetik 60 mg, 90 mg, dan 120 mg PCN-101 yang diberikan secara subkutan dibandingkan dengan 60 mg senyawa yang […]